Skip to main content
. 2021 Jul 23;27(4):589–602. doi: 10.3350/cmh.2021.0038

Figure 3.

Figure 3.

Kaplan-Meier survival curves of patients who had undergone liver transplantation for hepatocellular carcinoma. Time to recurrence (A) and overall survival (B) according to EVR use before propensity score matching. Time to recurrence (C) and overall survival (D) according to EVR after propensity score matching. EVR, everolimus.